Cencora (COR) Financial Analysis & Valuation | Quarter Chart
Cencora (COR)
CORPrice: $281.65
Fair Value: 🔒
🔒score
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related s... more
Cencora, Inc. sources and distributes pharmaceutical products in the United States and international... more
Description
Shares
| Market Cap | $54.80B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Distribution |
| Country | US | CEO | Robert Mauch |
| IPO Date | 1995-04-04 | CAGR | 0.15% |
| Employees | 47,000 | Website | www.cencora.com |
| Div. Yield | 0.81% | Payout Ratio | 0.18% |
| Buy Back Yield | — | Total Yield | 0.81% |
COR chart loading...
Fundamentals
Technicals
| Enterprise Value | $72.57B | P/E Ratio | 16.9 |
| Forward P/E | 14.5 | PEG Ratio | 0.17 |
| P/S Ratio | 0.16 | P/B Ratio | 16.53 |
| P/CF Ratio | 24.67 | P/FCF Ratio | 36.03 |
| EPS | $16.67 | EPS Growth 1Y | 51.33% |
| EPS Growth 3Y | 67.61% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 5.95% | Gross Margin | 0.03% |
| Operating Margin | 0.01% | Profit Margin | 0.01% |
| ROE | 1.16% | ROA | 0.03% |
| ROCE | 0.16% | Current Ratio | 0.95 |
| Quick Ratio | 0.59 | Cash Ratio | 0.04 |
| Debt/Equity | 3.65 | Interest Coverage | 8.86 |
| Altman Z Score | 4.66 | Piotroski Score | 5 |